News Updates
More Articles
- The Observatory of Good Regulatory Practices in the Regulation of Pharmaceutical Products: A Pioneering Initiative in Latin America
- Operational Excellence in an International Clinical Research Site Network
- Advancing the Implementation of ICH E17: Collaborative Efforts Driving Simultaneous Global Drug Development in China
- How to Build Partnerships for Sustainable Healthcare
- eCTD v4.0: A Look at 2025 and Beyond
Accelerated Approval as the New “Norm” in Gene Therapy for Rare Diseases
Accelerated Approval as the New “Norm” in Gene Therapy for Rare Diseases
This article examines two recent FDA draft guidance documents which reflect its commitment to ensuring that sponsors of drugs that are granted accelerated approval deliver on their confirmatory study obligations.
×
